Profil
Mira Leiwant is Senior VP-Quality, Regulatory & Clinical Affairs at Anika Therapeutics, Inc. since 2019.
Former roles include Senior Director-Regulatory & Quality Engineering at LifeCell Corp.
and Vice President-Regulatory Affairs at BTG International, Inc. Education includes undergraduate and graduate degrees from Cornell University, conferred in 1997 and 1998 respectively.
Postes actifs de Mira Leiwant
| Sociétés | Poste | Début |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 14/10/2019 |
Anciens postes connus de Mira Leiwant
| Sociétés | Poste | Fin |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Conseiller Juridique Général | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Formation de Mira Leiwant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
















